Drug Research
Pfizer Is Committed To Paxlovid Role In Stalling COVID-19
Pfizer is prepared and equipped to continue its pandemic sales supremacy, the company's chief executive said on a July 28Â investor call, even if federal contracts for COVID-19 antivirals and vaccines dry up.
During the company's second-quarter earnings call, CEO Albert...
Drug Research
GSK To Equip 12 European Nations For Likely Future Pandemic
People and the industry have learned a lot about pandemic management by living through COVID-19. Governments all throughout the world are placing a greater emphasis on pandemic preparedness.
In that respect, GSK is assisting 12 European nations in being ready...
Drug Research
Roche Launches Dual Antigen and Antibody Hepatitis C Diagnostic Test
Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.
Roche launched its Elecsys HCV Duo immunoassay (Elecsys) in July 2022, which is the first available immunoassay...
Drug Research
Merck and Orion Announce Global Collaboration for Oncology Drug
Merck, known as MSD outside the United States and Canada, and Orion Corporation are collaborating to develop and commercialize a treatment for metastatic castration-resistant prostate cancer.
Merck, known as MSD outside the United States and Canada, announced a global development...
Drug Research
Three Pharma MSMEs Programmes Launched By Indian Government
Three programmes were introduced by the Indian government on July 21st to support Micro, Small and Medium-Sized Enterprises (MSMEs) in the pharmaceutical industry. At the launch event, Mansukh Mandaviya, the Union Minister, said that the programmes call for the establishment...
Drug Research
Universal Coronavirus Monoclonal Therapy For COVID-19 Strain
Since 2019, the SARS-CoV-2 that produces COVID-19 has tragically highlighted the fragility of humanity to new coronaviruses by killing 6.3 million people globally.
In order to combat SARS-CoV-2 and all of its potentially dangerous variations, namely Beta, Gamma, Delta, Epsilon,...
Drug Research
FDA Examines 2 Other Cancer Approvals Without Revocation
The oncology division of the FDA has recently tightened regulations for expedited approvals and emphasised the significance of patient survival data. Several businesses promptly followed suit and withdrew questionable indicators when the agency applied more pressure. However, some businesses...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
